Article Details
Retrieved on: 2021-09-16 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In the Q2 2021 investor letter of Carillon Tower Advisers, the fund mentioned Moderna, Inc. (NASDAQ: MRNA) and discussed its stance on the firm.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here